It took the opioid epidemic to finally bring down specialty pharmaceutical company Mallinckrodt, whose fall from Wall Street grace seems almost complete. Just two days after a report it was considering a bankruptcy filing, Mallinckrodt said it had agreed to the biggest settlement yet by opioid manufacturers — for $30 million.
A
